Daily Stock Analysis, LNTH, Lantheus Holdings Inc, priceseries

Lantheus Holdings Inc. Daily Stock Analysis
Stock Information
Open
52.70
Close
51.77
High
54.10
Low
51.45
Previous Close
52.30
Daily Price Gain
-0.53
YTD High
54.10
YTD High Date
Mar 7, 2022
YTD Low
23.51
YTD Low Date
Jan 28, 2022
YTD Price Change
22.61
YTD Gain
77.54%
52 Week High
54.10
52 Week High Date
Mar 7, 2022
52 Week Low
18.82
52 Week Low Date
Mar 8, 2021
52 Week Price Change
32.65
52 Week Gain
170.76%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 26. 2017
12.05
May 30. 2017
16.55
23 Trading Days
37.36%
Link
LONG
Apr 12. 2018
15.75
May 4. 2018
17.45
16 Trading Days
10.81%
Link
LONG
Nov 23. 2018
16.15
Dec 6. 2018
17.29
8 Trading Days
7.05%
Link
LONG
Jan 31. 2019
16.82
Mar 6. 2019
22.77
23 Trading Days
35.38%
Link
LONG
Sep 10. 2019
22.41
Sep 27. 2019
25.27
13 Trading Days
12.77%
Link
LONG
Oct 24. 2019
19.24
Nov 18. 2019
21.09
17 Trading Days
9.60%
Link
LONG
Nov 23. 2020
12.88
Dec 29. 2020
14.39
24 Trading Days
11.70%
Link
LONG
Jan 29. 2021
16.27
Feb 23. 2021
18.93
16 Trading Days
16.32%
Link
LONG
Apr 21. 2021
21.54
May 4. 2021
22.94
9 Trading Days
6.51%
Link
LONG
May 27. 2021
22.78
Jul 9. 2021
27.31
29 Trading Days
19.87%
Link
LONG
Oct 29. 2021
23.39
Nov 18. 2021
29.00
14 Trading Days
23.99%
Link
LONG
Dec 20. 2021
27.52
Dec 31. 2021
29.06
8 Trading Days
5.60%
Link
Company Information
Stock Symbol
LNTH
Exchange
NasdaqGM
Company URL
http://www.lantheus.com
Company Phone
978 671-8001
CEO
Mary Anne Heino
Headquarters
Massachusetts
Business Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA 01862
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001521036
About

Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of innovative diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The company products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. It operates through the following segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sell its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 2007 and is headquartered in North Billerica, MA.

Description

Sells medical imaging agents used in the diagnosis of cardiovascular diseases.